Literature Review: Clinical Trial on the Effectiveness of Melatonin as an Alternative Medicine for COVID-19

Galih Ibnu Mukti; Indah Laily Hilmi; Salman Salman

Authors

Galih Ibnu Mukti Universitas Singaperbangsa Karawang
Indah Laily Hilmi Universitas Singaperbangsa Karawang
Salman Salman Universitas Singaperbangsa Karawang

Keywords:

Melatonin, Clinical trial, COVID-19

Abstract

Pandemic COVID-19 is one of the horrific events in history. It has leaves awareness of the need for more effective, cheap, and widely available drugs such as melatonin. In this literature review will discuss the effectiveness of melatonin against COVID-19 by reviewing clinical trial research conducted abroad with the aim of providing information that melatonin can be used in Indonesia for COVID-19 treatment therapy.

References

E. Mahase, “Covid-19: what treatments are being investigated?,” BMJ, vol. 368, p. m1252, Mar. 2020, doi: 10.1136/bmj.m1252.

V. Tiwari et al., “Current trends in diagnosis and treatment strategies of COVID-19 infection”, doi: 10.1007/s11356-021-16715-z/Published.

E. Burhan et al., PEDOMAN TATALAKSANA COVID-19 Edisi 4 TIM EDITOR Perhimpunan Dokter Paru Indonesia (PDPI) Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI) Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI) Perhimpunan Dokter Anestesiologi dan Terapi Intensif Indonesia (PERDATIN) Ikatan Dokter Anak Indonesia (IDAI). 2022.

W. Al-Zyoud and H. Haddad, “Dynamics prediction of emerging notable spike protein mutations in SARS-CoV-2 implies a need for updated vaccines,” Biochimie, vol. 191, pp. 91–103, Dec. 2021, doi: 10.1016/j.biochi.2021.08.011.

R. Zhang et al., “COVID-19: Melatonin as a potential adjuvant treatment,” Life Sciences, vol. 250. Elsevier Inc., Jun. 01, 2020. doi: 10.1016/j.lfs.2020.117583.

A. M. Seithikurippu R, “Melatonin, the Hormone of Darkness: From Sleep Promotion to Ebola Treatment,” Brain Disord Ther, vol. 04, no. 01, 2015, doi: 10.4172/2168-975x.1000151.

P. P. Posadzki et al., “Melatonin and health: An umbrella review of health outcomes and biological mechanisms of action,” BMC Med, vol. 16, no. 1, Feb. 2018, doi: 10.1186/s12916-017-1000-8.

J. A. Boga, A. Coto-Montes, S. A. Rosales-Corral, D. X. Tan, and R. J. Reiter, “Beneficial actions of melatonin in the management of viral infections: A new use for this ‘molecular handyman’?,” Reviews in Medical Virology, vol. 22, no. 5. pp. 323–338, Sep. 2012. doi: 10.1002/rmv.1714.

K. Bahrampour Juybari, M. H. Pourhanifeh, A. Hosseinzadeh, K. Hemati, and S. Mehrzadi, “Melatonin potentials against viral infections including COVID-19: Current evidence and new findings,” Virus Research, vol. 287. Elsevier B.V., Oct. 02, 2020. doi: 10.1016/j.virusres.2020.198108.

G. Farnoosh et al., “Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial,” Arch Med Res, vol. 53, no. 1, pp. 79–85, Jan. 2022, doi: 10.1016/j.arcmed.2021.06.006.

Z. T. Hasan, D. M. Q. Y. M. A. al Atrakji, and D. A. K. Mehuaiden, “The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients,” International Journal of Infectious Diseases, vol. 114. Elsevier B.V., pp. 79–84, Jan. 01, 2022. doi: 10.1016/j.ijid.2021.10.012.

A. Ziaei et al., “Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial,” Trials, vol. 21, no. 1. BioMed Central Ltd, Dec. 01, 2020. doi: 10.1186/s13063-020-04737-w.

S. A. Mousavi et al., “Melatonin effects on sleep quality and outcomes of COVID-19 patients: An open-label, randomized, controlled trial,” J Med Virol, vol. 94, no. 1, pp. 263–271, Jan. 2022, doi: 10.1002/jmv.27312.

N. Alizadeh et al., “High dose melatonin as an adjuvant therapy in intubated patients with COVID-19: A randomized clinical trial,” J Taibah Univ Med Sci, vol. 17, no. 3, pp. 454–460, Jun. 2022, doi: 10.1016/j.jtumed.2022.04.012.

M. Sabbatucci et al., “Clinical Medicine Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical Trial,” J. Clin. Med, vol. 2022, p. 1139, 2022, doi: 10.3390/jcm.

C. Fogleman et al., “A Pilot of a Randomized Control Trial of Melatonin and Vitamin C for Mild-to-Moderate COVID-19,” J Am Board Fam Med, vol. 35, no. 4, pp. 695–707, Jul. 2022, doi: 10.3122/jabfm.2022.04.210529.

R. R. Castillo et al., “Melatonin as adjuvant treatment for coronavirus disease 2019 pneumonia patients requiring hospitalization (MAC-19 PRO): a case series,” Melatonin Research, vol. 3, no. 3, pp. 297–310, Jun. 2020, doi: 10.32794/mr11250063.

E. Karimpour-razkenari, F. Naderi-Behdani, A. Salahshoor, F. Heydari, A. Alipour, and A. G. Baradari, “Melatonin as adjunctive therapy in patients admitted to the Covid-19,” Annals of Medicine and Surgery, vol. 76, Apr. 2022, doi: 10.1016/j.amsu.2022.103492.

C. S. Shi, N. R. Nabar, N. N. Huang, and J. H. Kehrl, “SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes,” Cell Death Discov, vol. 5, no. 1, Dec. 2019, doi: 10.1038/s41420-019-0181-7.

S. M. Man, R. Karki, and T. D. Kanneganti, “Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases,” Immunological Reviews, vol. 277, no. 1. Blackwell Publishing Ltd, pp. 61–75, May 01, 2017. doi: 10.1111/imr.12534.

S. Ma et al., “Melatonin ameliorates the progression of atherosclerosis via mitophagy activation and NLRP3 inflammasome inhibition,” Oxid Med Cell Longev, vol. 2018, 2018, doi: 10.1155/2018/9286458.

V. Srinivasan, M. Mohamed, and H. Kato, “Melatonin in Bacterial and Viral Infections with Focus on Sepsis: A Review,” 2012.

E. L. Feitosa et al., “Covid-19: Rational discovery of the therapeutic potential of melatonin as a sars-cov-2 main protease inhibitor,” Int J Med Sci, vol. 17, no. 14, pp. 2133–2146, 2020, doi: 10.7150/ijms.48053.

O. A. Khomich, S. N. Kochetkov, B. Bartosch, and A. v. Ivanov, “Redox biology of respiratory viral infections,” Viruses, vol. 10, no. 8. MDPI AG, Aug. 01, 2018. doi: 10.3390/v10080392.

R. J. Reiter, J. C. Mayo, D. X. Tan, R. M. Sainz, M. Alatorre-Jimenez, and L. Qin, “Melatonin as an antioxidant: under promises but over delivers,” Journal of Pineal Research. Blackwell Publishing Ltd, pp. 253–278, Oct. 01, 2016. doi: 10.1111/jpi.12360.